Pharmacokinetic considerations for therapies used to treat interstitial cystitis

Author： Gardella Barbara   Porru Daniele   Allegri Massimo   Bogliolo Stefano   Iacobone Anna Daniela   Minella Cristina   Nappi Rossella Elena   Ferrero Simone   Spinillo Arsenio  

Publisher： Informa Healthcare

ISSN： 1742-5255

Source： Expert Opinion on Drug Metabolism and Toxicology, Vol.10, Iss.5, 2014-05, pp. : 673-684

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Pharmacokinetic considerations for antithrombotic therapies in stroke

By Apostolakis Stavros   Lip Gregory YH   Shantsila Eduard  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1335-1347

Informa Healthcare

Access to resources Recommend Favorite

Advances in the treatment of interstitial cystitis

By Parsons C Lowell  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 4, 2006-03 ,pp. : 411-419

Informa Healthcare

Access to resources Recommend Favorite

Interstitial cystitis costs "substantial"

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 559, 2008-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome

By Mozaffari Shilan   Nikfar Shekoufeh   Abdollahi Mohammad  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 4, 2013-04 ,pp. : 403-421

Informa Healthcare

Access to resources Recommend Favorite

Current strategies for managing interstitial cystitis

By Parsons C Lowell  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 2, 2004-02 ,pp. : 287-293

Informa Healthcare

Access to resources Recommend Favorite